Geode Capital Management, LLC Xeris Biopharma Holdings, Inc. Transaction History
Geode Capital Management, LLC
- $1.52 Trillion
- Q3 2025
A detailed history of Geode Capital Management, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 4,140,174 shares of XERS stock, worth $30 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,140,174
Previous 3,650,688
13.41%
Holding current value
$30 Million
Previous $17 Million
96.71%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding XERS
# of Institutions
236Shares Held
94.1MCall Options Held
251KPut Options Held
61.8K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
-
Qube Research & Technologies LTD London, X03.27MShares$23.7 Million0.03% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...